Sensible Diagnostics

Sensible Diagnostics is a point-of-care molecular diagnostics company. The company is developing a test that can be completed in 10-15 minutes, with costs equal to or lower than current molecular tests and CLIA-waived antigen tests. Sensible is also developing a separate test for Group A Streptococcus and plans to develop additional tests for sexually transmitted infections, including Hepatitis C and HIV, as well as a newborn infectious disease screening method.